← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Inbios International, Inc.
Seattle, WA
$11,629,439
Total funding
16
Grants
Funding over time
peak $1.4M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,629,439 · 16
By mechanism
R44$4,570,070 · 3
R43$2,780,738 · 7
R42$1,994,739 · 1
R41$1,584,442 · 3
N43$699,450 · 2
Investigators at Inbios International, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease$999,997
R44 · FY2024 · AI
Development of Next-gen Chagas DetectTM Plus Rapid test for sensitive and specific diagnosis of Chagas disease$988,977
R44 · FY2025 · AI
Antigen Detection assay for the Diagnosis of Melioidosis$700,138
R42 · FY2016 · AI
Antigen Detection assay for the Diagnosis of Melioidosis$673,521
R42 · FY2015 · AI
Antigen Detection assay for the Diagnosis of Melioidosis$621,080
R42 · FY2014 · AI
Development of rapid detection tests for B pseudomallei$541,271
R43 · FY2006 · AI
Geographically robust rapid assay for T. cruzi infection$530,883
R44 · FY2009 · AI
Geographically robust rapid assay for T. cruzi infection$470,363
R44 · FY2004 · AI
Development of rapid detection tests for B pseudomallei$465,727
R43 · FY2005 · AI
Geographically robust rapid assay for T. cruzi infection$459,198
R44 · FY2010 · AI
TOPIC 455: DEVELOPMENT OF A RAPID AT-HOME TEST TO DETECT PROSTATE-SPECIFIC ANTIGEN USING SELF-COLLECTED FINGER STICKBLOOD$399,866
N43 · FY2024 · CA
New Generation Test for Visceral Leishmaniasis Diagnosis$391,863
R44 · FY2001 · AI
Antigen Detection Assay for Tuberculosis$386,997
R41 · FY2006 · AI
Geographically robust rapid assay for T. cruzi infection$381,820
R44 · FY2005 · AI
Rapid antigen detection test for Dengue infection$375,019
R43 · FY2007 · AI
New Generation Test for Visceral Leishmaniasis Diagnosis$346,969
R44 · FY2002 · AI
Development of rapid detection tests for Brucella species$329,004
R43 · FY2006 · AI
Rapid antigen detection test for Dengue infection$309,725
R43 · FY2008 · AI
Antigen Detection Assay for the Diagnosis of Melioidosis$299,699
R41 · FY2012 · AI
Antigen Detection Assay for the Diagnosis of Melioidosis$299,699
R41 · FY2013 · AI